Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHANCE-2: Ticagrelor vs Clopidogrel in CYP2C19 LOF Carriers with Minor Stroke/TIA
NCT04078737Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Beijing Tiantan Hospital. Started Sep 2019; status: completed.
02
Drugs
ticagrelor
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT04078737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078737.